Stocks and Investing Stocks and Investing
Fri, January 6, 2023
Thu, January 5, 2023
Wed, January 4, 2023
Tue, January 3, 2023

Stephen Baxter Maintained (THC) at Buy with Increased Target to $59 on, Jan 3rd, 2023


Published on 2024-10-28 00:42:31 - WOPRAI, Stephen Baxter
  Print publication without navigation


Stephen Baxter of Wells Fargo, Maintained "Tenet Healthcare Corporation" (THC) at Buy with Increased Target from $48 to $59 on, Jan 3rd, 2023.

Stephen has made no other calls on THC in the last 4 months.



There are 8 other peers that have a rating on THC. Out of the 8 peers that are also analyzing THC, 1 agrees with Stephen's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Scott Fidel of "Stephens & Co." Maintained at Hold with Decreased Target to $45 on, Monday, October 24th, 2022


These are the ratings of the 7 analyists that currently disagree with Stephen


  • Ann Hynes of "Mizuho" Maintained at Strong Buy with Decreased Target to $60 on, Wednesday, November 2nd, 2022
  • Jamie Perse of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $80 on, Tuesday, November 1st, 2022
  • John Ransom of "Raymond James" Maintained at Strong Buy with Decreased Target to $80 on, Thursday, October 27th, 2022
  • Jason Cassorla of "Citigroup" Maintained at Strong Buy with Decreased Target to $76 on, Tuesday, October 25th, 2022
  • Whit Mayo of "SVB Leerink" Maintained at Buy with Decreased Target to $55 on, Tuesday, October 25th, 2022
  • Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $48 on, Monday, October 24th, 2022
  • Sarah James of "Barclays" Maintained at Buy with Decreased Target to $67 on, Monday, October 24th, 2022